Call 888-309-1224
To let us begin helping you today
In an effort to begin to unleash the logjam of 25,000 plus Ethicon Vaginal mesh suits in federal court, U.S. District Judge Joseph Goodwin in the Southern District of West Virginia set a November 2, 2015 trial date for 26 Ethicon cases. Ethicon, which is a Johnson...
In what thousands of women hope is a sign of a change in philosophy, on the fourth day of trial in a bellwether case before the Hon Joseph R. Goodwin, Ethicon and J&J entered into a settlement of the case brought by Diane M. Bellew, who had a Ethicon Prolift...
A California jury rendered a $5.6 million dollar verdict against Johnson & Johnson’s Ethicon Unit in the first trial against the TVT Abbrevo in Kern County, California. Jurors found the manufacturer was liable for design defect and for failing to warn about its...
On November 20, 2014, a jury in Charleston, West Virginia Federal court found the Massachusetts Company liable to four women following a 10-day trial and determined damages for each of the four women ranging from $3.25 million to $4.25 million for the injuries. The...
A Federal jury in Miami, Florida awarded $27 million to four women who were injured by defective mesh product manufactured by Boston Scientific. Boston Scientific will not face additional punitive damages. The jury returned a verdict finding negligence by Boston...
In the first victory for plaintiffs against Boston Scientific Corp. and their mesh devices, a Dallas, Texas jury found for the plaintiff Martha Salazar and ordered Boston Scientific to pay a staggering $73 million. Jurors found Boston Scientific to be at fault for...
In another victory for plaintiffs against vaginal-mesh implant manufacturers, a federal jury in West Virginia found for the plaintiff Jo Huskey and ordered Johnson & Johnson to pay $3.27 million. Jurors found that J&J defectively designed the Ethicon TVT-O...
Seeing the writing on the wall, Endo International announced on May 1, 2014 that they will pay $830 million to settle 20,000 cases involving women implanted with the AMS transvaginal mesh unit. Click here to read the full article: Endo’s AMS Unit Settles 20,000...
Based on a number of risks associated with the transvaginal mesh devices including infection, vaginal bleeding, damage to connective tissues, nerves, and blood vessels, on May 1, 2014, the FDA proposed reclassification of mesh devices from Class 2 to the more rigorous...
Endo International PLC, a subsidiary of American Medical Systems, Inc. was recently issued a warning letter by the FDA for violating three federal regulations relating to how the Minnesota company facility manufactures its urological devices. Click here to read the...